When the mice were sacrificed at the end of 60 days, body weight was significantly increased and tumor volume was decreased in the mice injected with MDA-MB-231-P2Y2R-shRNA compared to the mice injected with MDA-MB-231-EV (Fig 5A-C). Here, P2RY2 is linked to neoplasm.